73 related articles for article (PubMed ID: 24369166)
1. [Significance of sTfR and sTfR/E levels in the assessment of bone marrow hematopoietic function in patients with myelodysplastic syndrome].
Yang B; Yang Y; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1060-2. PubMed ID: 24369166
[No Abstract] [Full Text] [Related]
2. Soluble transferrin receptor and its ratio to erythroblasts in bone marrow may be a new diagnostic tool to distinguish between aplastic and refractory anemia.
Matsuda A; Misumi M; Shimada T; Yoshida K; Yagasaki F; Ito Y; Kawai N; Murohashi I; Hirashima K; Bessho M
Acta Haematol; 2004; 111(3):138-42. PubMed ID: 15034234
[TBL] [Abstract][Full Text] [Related]
3. [Histopathology and morphometry of hematopoiesis in bone marrow of AIDS patients in comparison with patients with myelodysplastic syndrome].
Kaloutsi V; Maschek H; Kohlmeyer U; Nafe R; Choritz H; Amor A; Georgii A
Verh Dtsch Ges Pathol; 1991; 75():131-5. PubMed ID: 1724815
[TBL] [Abstract][Full Text] [Related]
4. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
[TBL] [Abstract][Full Text] [Related]
5. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.
Di Savino A; Gaidano V; Palmieri A; Crasto F; Volpengo A; Lorenzatti R; Scaravaglio P; Manello A; Nicoli P; Gottardi E; Saglio G; Cilloni D; De Gobbi M
Br J Haematol; 2017 Feb; 176(3):491-495. PubMed ID: 26914246
[No Abstract] [Full Text] [Related]
7. The ratio of sTfR/ferritin is associated with the expression level of TfR in rat bone marrow cells after endurance exercise.
Tian Y; Zhao J; Zhao B; Gao Q; Xu J; Liu D
Biol Trace Elem Res; 2012 Jun; 147(1-3):261-6. PubMed ID: 22207220
[TBL] [Abstract][Full Text] [Related]
8. [A feature of hematological findings in myelodysplastic syndromes].
Bando S; Niiya T; Murase M; Makino H
Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
10. CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome.
Jiang H; Fu R; Wang H; Li L; Liu H; Shao Z
Leuk Res; 2013 Aug; 37(8):907-10. PubMed ID: 23642736
[TBL] [Abstract][Full Text] [Related]
11. [Biology and clinical aspects of primary myelodysplastic syndromes].
Urbańska-Ryś H; Robak T; Krykowski E
Pol Tyg Lek; 1988 Feb; 43(7):225-9. PubMed ID: 3043403
[No Abstract] [Full Text] [Related]
12. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
[TBL] [Abstract][Full Text] [Related]
13. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.
Wu L; Li X; Chang C; Ying S; He Q; Pu Q
Int J Lab Hematol; 2008 Oct; 30(5):390-9. PubMed ID: 19046314
[TBL] [Abstract][Full Text] [Related]
14. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
16. Serum prohepcidin level in myelodysplasia.
El Husseiny NM; Matter MM; Sabry RM; Amin IS
Scand J Clin Lab Invest; 2010 Sep; 70(5):343-6. PubMed ID: 20509758
[TBL] [Abstract][Full Text] [Related]
17. Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages.
Katagiri T; Kawamoto H; Nakakuki T; Ishiyama K; Okada-Hatakeyama M; Ohtake S; Seiki Y; Hosokawa K; Nakao S
Stem Cells; 2013 Mar; 31(3):536-46. PubMed ID: 23316019
[TBL] [Abstract][Full Text] [Related]
18. Relationship between soluble transferrin receptors in serum and membrane-bound transferrin receptors.
Kuiper-Kramer EP; Coenen JL; Huisman CM; Abbes A; van Raan J; van Eijk HG
Acta Haematol; 1998; 99(1):8-11. PubMed ID: 9490571
[TBL] [Abstract][Full Text] [Related]
19. [The role of bone marrow stromal cells in apoptosis in myelodysplastic syndrome].
Yaguchi M; Aizawa M; Toriyama K
Rinsho Ketsueki; 1996 Jul; 37(7):542-6. PubMed ID: 8779769
[No Abstract] [Full Text] [Related]
20. Serum transferrin receptor concentration and its ratio to bone marrow erythroblasts in iron deficiency anemia and anemia of chronic diseases.
Choi JW
Ann Clin Lab Sci; 2007; 37(3):288-90. PubMed ID: 17709697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
